YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Discover Continuous
Calm In Uveitis

This site is intended for US healthcare professionals only.

Address:

480 Pleasant Street
Suite B300
Watertown, MA 02472
1-833-EyePoint (1-833-393-7646)

Address:
480 Pleasant Street
Suite B300
Watertown, MA 02472
1-833-EyePoint (1-833-393-7646)

This site is intended for US healthcare professionals only.

Media gallery

Choose a video to hear multiple aspects of disease treatment, patient care, and the use of YUTIQ.

YUTIQ in practice: a CEO's perspective

Jeff Brockette, CEO, Texas Retina Associates

Listen to the CEO of Texas Retina Specialists discuss EyePoint support, getting started with YUTIQ, and HUB enrollment.

Video thumbnail of CEO Jeff Brockette discussing Eye Point support and the initial steps to start YUTIQ®
Play Video

Healthcare specialists

Dr David Callanan

Uveitis specialist, Texas Retina Associates

Chapter 1

Video thumbnail of Dr. David Callanan discussing patient type and uveitis treatment best practices and challenges.
Play Video

Dr Callanan discusses patient type, treatment challenges, best treatment practices, and comanagement with other specialists.

Chapter 2

Video thumbnail of Dr. David Callanan discussing the use of YUTIQ, potential side effects and the ideal patient, with an inset of patient’s eye during the injection administration.
Play Video

Dr Callanan discusses the use and potential side effects of YUTIQ as well as the ideal patient. An inset of the injection being performed accompanies this video.

Chapter 3

Video thumbnail of Dr. David Callanan discussing YUTIQ support and follow-up for patients.
Play Video
Dr Callanan discusses YUTIQ support and patient follow-up.

Dr David Eichenbaum

Retina specialist, Retina Vitreous Associates of Florida

Chapter 1

Video of Dr. David Eichenbaum discussing chronic uveitis, treatment, referring patients and comanagement with other uveitis specialists.
Play Video

Dr Eichenbaum discusses disease overview, best treatment practices, patient referral, and comanagement with other specialists.

Chapter 2

Video thumbnail of Dr. David Eichenbaum discussing ideal patient, use and follow-up care for YUTIQ.
Play Video

Dr Eichenbaum discusses the ideal YUTIQ patient, use of YUTIQ, and follow-up care.

Dr Sumit Sharma

Uveitis specialist, Cleveland Clinic

Chapter 1

Video of Dr. Sumit Sharma discussing uveitis treatment and patient types.
Play Video

Dr Sharma discusses treatment challenges, the various patient types, and best treatment practices.

Chapter 2

Video of Dr. Sumit Sharma discussing YUTIQ use with patients and follow-up.
Play Video

Dr Sharma discusses the use of YUTIQ and patient follow-up.

Dr Michael Singer

Retina specialist, Medical Center Ophthalmology Associates, San Antonio, TX

Chapter 1

Video thumbnail of Dr. Michael Singer discussing chronic, non-infectious uveitis challenges, patient types and referrals.
Play Video
Dr Singer discusses treatment challenges, patient types, and patient referral.

Chapter 2

Video thumbnail of Dr. Michael Singer discussing the ideal patient, use and follow-up for YUTIQ and performs a YUTIQ injection on an actual patient.
Play Video

After Dr Singer speaks about the ideal patient, use of YUTIQ, and patient follow-up, he performs a YUTIQ injection on an actual patient in his office.

Dr Robert Wang

Uveitis specialist, Texas Retina Associates

Chapter 1

Video thumbnail of Dr. Robert Wang discussing treatment challenges for chronic, non-infectious uveitis, referring patients and comanagement with other uveitis specialists.
Play Video
Dr Wang discusses treatment challenges, patient referral, and comanagement with other specialists.

Chapter 2

Video thumbnail of Dr. Robert Wang discussing preparing to start YUTIQ injections in office, company support and ideal patients. YUTIQ injection on actual patient included in video.
Play Video

Dr Wang discusses how he and his team prepared to begin injecting YUTIQ in their office, including support from the company and identifying patients. He then performs the injection in an actual patient.

Patient testimonial

Vickie R, patient

Listen to one patient tell her story about chronic noninfectious posterior uveitis and her treatment with YUTIQ. This is one patient’s experience. Your experience may differ.

Video thumbnail of a patient discussing her experience with chronic uveitis and YUTIQ®
Play Video